Novel Drug-Drug Interaction of Potential Rifabutin-Induced Edoxaban Failure: A Case Report
Author:
Affiliation:
1. Ballad Health, Johnson City Medical Center, Johnson City, TN, USA
2. Department of Internal Medicine, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA
Abstract
Publisher
SAGE Publications
Subject
Pharmacology (medical)
Link
http://journals.sagepub.com/doi/pdf/10.1177/08971900231213702
Reference30 articles.
1. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism
3. Oral Apixaban for the Treatment of Acute Venous Thromboembolism
4. Apixaban versus Warfarin in Patients with Atrial Fibrillation
5. Edoxaban versus Warfarin in Patients with Atrial Fibrillation
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3